Aardvark Therapeutics, Inc.
Nasdaq · CIK 0001774857 · Fiscal year end 1231
Latest reported period: Latest published period
Operating Income
$-22.5M
Net Income
$-21.6M
Eps Basic
-0.99
Recent financials
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-22.5M | - | - |
| Net Income | $-21.6M | - | - |
| Eps Basic | -0.99 | - | - |
| Eps Diluted | -0.99 | - | - |
| Cash And Equivalents | $62.4M | - | - |
| Total Assets | $98.6M | - | - |
| Total Liabilities | $11.6M | - | - |
| Shareholders Equity | $87.0M | - | - |
| Operating Cash Flow | $-18.9M | - | - |
Latest filings
| Form | Company | Filed | Accession |
|---|---|---|---|
| 10-Q | Aardvark Therapeutics, Inc. | 2026-05-07 | 0001193125-26-210675 |